MAINZ BIOMED B.V. EO 1 news, videos and press releases - Page 4
For more news please use our advanced search feature.
MAINZ BIOMED B.V. EO 1 - More news...
MAINZ BIOMED B.V. EO 1 - More news...
- EQS-News: Mainz Biomed to Present at the Cantor Fitzgerald Global Healthcare Conference
- Mainz Biomed to Present at the Cantor Fitzgerald Global Healthcare Conference
- EQS-News: Mainz Biomed’s ColoFuture Study, Evaluating its Novel mRNA Biomarkers, Reports Groundbreaking Topline Results Demonstrating Sensitivity for Colorectal Cancer of 94% with Specificity of 97% and Advance
- Mainz Biomed’s ColoFuture Study, Evaluating its Novel mRNA Biomarkers, Reports Groundbreaking Topline Results Demonstrating Sensitivity for Colorectal Cancer of 94% with Specificity of 97% and Advanced Adenoma Sensitivity of 81%
- EQS-News: Mainz Biomed Announces Strategic Partnership with Ärztliches Labor Dr. Buhlmann, Expanding Footprint in German Market
- Mainz Biomed Announces Strategic Partnership with Ärztliches Labor Dr. Buhlmann, Expanding Footprint in German Market
- EQS-News: Mainz Biomed to Present at the H.C. Wainwright Global Investment Conference
- Mainz Biomed to Present at the H.C. Wainwright Global Investment Conference
- EQS-News: Mainz Biomed Announces Live Launch of ColoAlert® with testDNA Laboratory in Poland
- Mainz Biomed Announces Live Launch of ColoAlert® with testDNA Laboratory in Poland
- EQS-News: Mainz Biomed Announces Financial Half Year Results 2023 and Provides Corporate Update
- Mainz Biomed Announces Financial Half Year Results 2023 and Provides Corporate Update
- EQS-News: Mainz Biomed Announces Live Launch of ColoAlert® with Marylebone Laboratory in the United Kingdom
- Mainz Biomed Announces Live Launch of ColoAlert® with Marylebone Laboratory in the United Kingdom
- EQS-News: Mainz Biomed Announces Collaboration with Fugene Genetics in Israel
- Mainz Biomed Announces Collaboration with Fugene Genetics in Israel
- Mainz Biomed Secures up to $50M in New Funding
- EQS-News: Mainz Biomed Secures up to $50M in New Funding
- EQS-News: Mainz Biomed to Attend ESMO World Congress on Gastrointestinal Cancer 2023 in Barcelona, Spain
- Mainz Biomed to Attend ESMO World Congress on Gastrointestinal Cancer 2023 in Barcelona, Spain
- EQS-News: Mainz BioMed N.V.: Mainz Biomed Expands into Romania Through Partnership with Bioclinica
- Mainz Biomed Expands into Romania Through Partnership with Bioclinica
- EQS-News: Mainz Biomed Expands Commercial Footprint into Poland
- Mainz Biomed Expands Commercial Footprint into Poland
- EQS-News: Mainz Biomed Processes First Patients from Colorectal Cancer Screening Campaign Through its Corporate Health Portal in Partnership with Zöller-Kipper
- Mainz Biomed Processes First Patients from Colorectal Cancer Screening Campaign Through its Corporate Health Portal in Partnership with Zöeller-Kipper
- EQS-News: Mainz Biomed Announces First Quarter 2023 Financial Results and Provides Corporate Update
- Mainz Biomed Announces First Quarter 2023 Financial Results and Provides Corporate Update
- EQS-News: Mainz Biomed Partners with Microba Life Sciences for the Development of PancAlert
- Mainz Biomed Partners with Microba Life Sciences for the Development of PancAlert
